NGS Technology Firm Stratos Genomics Raises $10M | GenomeWeb

NEW YORK (GenomeWeb) – Stratos Genomics has raised $10 million toward a Series B financing round targeting $16.3 million.

The Seattle-based firm disclosed the raise in a Form D filed with the US Securities and Exchange Commission on Monday. In an email to GenomeWeb Daily News, Stratos Chairman and CEO Alan Stephan said the $10 million is the first close of a Series B round. He declined to comment further, saying more information will be released after the second close is completed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.